Advisory Committee on Immunization Practices (ACIP); Amended Notice of Meeting, 47644-47645 [2021-18453]
Download as PDF
<![CDATA[
jbell on DSKJLSW7X2PROD with NOTICES
47644
Federal Register / Vol. 86, No. 163 / Thursday, August 26, 2021 / Notices
Filed Date: 8/19/21.
Accession Number: 20210819–5211.
Comment Date: 5 pm ET 9/9/21.
Docket Numbers: ER21–2728–000.
Applicants: California Independent
System Operator Corporation.
Description: § 205(d) Rate Filing:
2021–08–20 PLA No. 4 Time Ext—
CDWR to be effective 11/1/2021.
Filed Date: 8/20/21.
Accession Number: 20210820–5120.
Comment Date: 5 pm ET 9/10/21.
Docket Numbers: ER21–2729–000.
Applicants: Black Hills Power, Inc.
Description: § 205(d) Rate Filing:
Update to Schedule 2 of the Joint Open
Access Transmission Tariff to be
effective 10/19/2021.
Filed Date: 8/20/21.
Accession Number: 20210820–5130.
Comment Date: 5 pm ET 9/10/21.
Docket Numbers: ER21–2730–000.
Applicants: Unitil Energy Systems,
Inc.
Description: § 205(d) Rate Filing:
Interim Distribution Wheeling
Agreement with Briar Hydro to be
effective 8/23/2021.
Filed Date: 8/20/21.
Accession Number: 20210820–5132.
Comment Date: 5 pm ET 9/10/21.
Take notice that the Commission
received the following electric securities
filings:
Docket Numbers: ES21–65–000.
Applicants: Interstate Power and
Light Company.
Description: Application Under
Section 204 of the Federal Power Act for
Authorization to Issue Securities of
Interstate Power and Light Company.
Filed Date: 8/18/21.
Accession Number: 20210818–5170.
Comment Date: 5 pm ET 9/8/21.
The filings are accessible in the
Commission’s eLibrary system (https://
elibrary.ferc.gov/idmws/search/
fercgensearch.asp) by querying the
docket number.
Any person desiring to intervene or
protest in any of the above proceedings
must file in accordance with Rules 211
and 214 of the Commission’s
Regulations (18 CFR 385.211 and
385.214) on or before 5:00 p.m. Eastern
time on the specified comment date.
Protests may be considered, but
intervention is necessary to become a
party to the proceeding.
eFiling is encouraged. More detailed
information relating to filing
requirements, interventions, protests,
service, and qualifying facilities filings
can be found at: https://www.ferc.gov/
docs-filing/efiling/filing-req.pdf. For
other information, call (866) 208–3676
(toll free). For TTY, call (202) 502–8659.
VerDate Sep<11>2014
17:30 Aug 25, 2021
Jkt 253001
Dated: August 20, 2021.
Kimberly D. Bose,
Secretary.
[FR Doc. 2021–18376 Filed 8–25–21; 8:45 am]
BILLING CODE 6717–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meetings
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of five AHRQ
subcommittee meetings.
AGENCY:
will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. app. 2 section 10(d), 5 U.S.C.
552b(c)(4), and 5 U.S.C. 552b(c)(6). The
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for these meetings are
subject to change as priorities dictate.
Dated: August 18, 2021.
Marquita Cullom,
Associate Director.
[FR Doc. 2021–18428 Filed 8–25–21; 8:45 am]
The subcommittees listed
below are part of AHRQ’s Health
Services Research Initial Review Group
Committee. Grant applications are to be
reviewed and discussed at these
meetings. Each subcommittee meeting
will be closed to the public.
DATES: See below for dates of meetings:
1. Healthcare Effectiveness and
Outcomes Research (HEOR)
Date: October 13–14, 2021
2. Healthcare Safety and Quality
Improvement Research (HSQR)
Date: October 13–14, 2021
3. Health Care Research and Training
(HCRT)
Date: October 14–15, 2021
4. Health System and Value Research
(HSVR)
Date: October 14–15, 2021
5. Healthcare Information Technology
Research (HITR)
Date: October 21–22, 2021
ADDRESSES: Agency for Healthcare
Research and Quality (Virtual Review),
5600 Fishers Lane, Rockville, Maryland
20857.
FOR FURTHER INFORMATION CONTACT: (To
obtain a roster of members, agenda or
minutes of the non-confidential portions
of the meetings.)
Jenny Griffith, Committee
Management Officer, Office of
Extramural Research Education and
Priority Populations, Agency for
Healthcare Research and Quality
(AHRQ), 5600 Fishers Lane, Rockville,
Maryland 20857, Telephone (301) 427–
1557.
SUPPLEMENTARY INFORMATION: In
accordance with section 10(a)(2) of the
Federal Advisory Committee Act (5
U.S.C. app. 2), AHRQ announces
meetings of the above-listed scientific
peer review groups, which are
subcommittees of AHRQ’s Health
Services Research Initial Review Group
Committee. The subcommittee meetings
SUMMARY:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2021–0089]
Advisory Committee on Immunization
Practices (ACIP); Amended Notice of
Meeting
Centers for Disease Control and
Prevention, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the Advisory
Committee on Immunization Practices
(ACIP). This meeting is open to the
public. Time will be available for public
comment. The meeting will be webcast
live via the World Wide Web; for more
information on ACIP please visit the
ACIP website: https://www.cdc.gov/
vaccines/acip/.
DATES: The meeting will be held on
August 30, 2021 and August 31, 2021,
from 10:00 a.m. to 4:00 p.m., EDT (times
subject to change). The docket is
currently open to receive written
comments. Written comments must be
received on or before August 31, 2021.
A notice of this ACIP meeting has also
been posted on CDC’s ACIP website at:
https://www.cdc.gov/vaccines/acip/
index.html. In addition, CDC has sent
notice of this ACIP meeting by email to
those who subscribe to receive email
updates about ACIP.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0089 by any of the following methods:
SUMMARY:
E:\FR\FM\26AUN1.SGM
26AUN1
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 163 / Thursday, August 26, 2021 / Notices
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Centers for Disease Control
and Prevention, 1600 Clifton Road NE,
MS H24–8, Atlanta, Georgia 30329–
4027, Attn: August 30–31, 2021 ACIP
Meeting.
Instructions: All submissions received
must include the Agency name and
Docket Number. All relevant comments
received in conformance with the
https://www.regulations.gov suitability
policy will be posted without change to
https://www.regulations.gov, including
any personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee
Management Specialist, Centers for
Disease Control and Prevention,
National Center for Immunization and
Respiratory Diseases, 1600 Clifton Road
NE, MS–H24–8, Atlanta, GA 30329–
4027; Telephone: 404–639–8367; Email:
ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION: Notice is
hereby given of a change in the meeting
of the Advisory Committee on
Immunization Practices (ACIP); August
24, 2021, 10:00 a.m.–5:00 p.m., EDT
(times subject to change), in the original
FRN.
The virtual meeting was published in
the Federal Register on Wednesday,
August 18, 2021, Volume 86, Number
157, pages 46256–46257.
The virtual meeting is being amended
to change the dates to August 30, 2021
and August 31, 2021, update meeting
times and supplemental information.
In accordance with 41 CFR 102–
3.150(b), less than 15 calendar days’
notice is being given for this meeting
due to the exceptional circumstances of
the COVID–19 pandemic and rapidly
evolving COVID–19 vaccine
development and regulatory processes.
A notice of this ACIP meeting has also
been posted on CDC’s ACIP website at:
https://www.cdc.gov/vaccines/acip/
index.html. In addition, CDC has sent
notice of this ACIP meeting by email to
those who subscribe to receive email
updates about ACIP.
Purpose: The committee is charged
with advising the Director, CDC, on the
use of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is
mandated to establish and periodically
review and, as appropriate, revise the
list of vaccines for administration to
vaccine-eligible children through the
Vaccines for Children (VFC) program,
along with schedules regarding dosing
interval, dosage, and contraindications
VerDate Sep<11>2014
17:30 Aug 25, 2021
Jkt 253001
to administration of vaccines. Further,
under provisions of the Affordable Care
Act, section 2713 of the Public Health
Service Act, immunization
recommendations of the ACIP that have
been approved by the Director of the
Centers for Disease Control and
Prevention and appear on CDC
immunization schedules must be
covered by applicable health plans.
Matters To Be Considered: The agenda
will include discussions on Pfizer’s
COVID–19 vaccine, and additional
discussions on mRNA booster doses. A
recommendation vote on Pfizer’s
COVID–19 vaccine is planned. No
Vaccines for Children (VFC) votes are
scheduled. Agenda items are subject to
change as priorities dictate. For more
information on the meeting agenda visit
https://www.cdc.gov/vaccines/acip/
meetings/meetings-info.html.
Meeting Information: The meeting
will be webcast live via the World Wide
Web; for more information on ACIP
please visit the ACIP website: https://
www.cdc.gov/vaccines/acip/.
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data. Please note that comments
received, including attachments and
other supporting materials, are part of
the public record and are subject to
public disclosure. Comments will be
posted on https://www.regulations.gov.
Therefore, do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
Oral Public Comment: This meeting
will include time for members of the
public to make an oral comment. Oral
public comment will occur before any
scheduled votes including all votes
relevant to the ACIP’s Affordable Care
Act and Vaccines for Children Program
roles. Priority will be given to
individuals who submit a request to
make an oral public comment before the
meeting according to the procedures
below.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
47645
Procedure for Oral Public Comment:
All persons interested in making an oral
public comment at the August 30, 2021,
ACIP meeting must submit a request at
https://www.cdc.gov/vaccines/acip/
meetings/ no later than 11:59 p.m., EDT,
August 28, 2021, according to the
instructions provided.
If the number of persons requesting to
speak is greater than can be reasonably
accommodated during the scheduled
time, CDC will conduct a lottery to
determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
by August 29, 2021. To accommodate
the significant interest in participation
in the oral public comment session of
ACIP meetings, each speaker will be
limited to 3 minutes, and each speaker
may only speak once per meeting.
Written Public Comment: The docket
is currently open to receive written
comments. Written comments must be
received on or before August 31, 2021.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–18453 Filed 8–24–21; 11:15 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2021–N–0008]
General and Plastic Surgery Devices
Panel of the Medical Devices Advisory
Committee; Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) announces a
forthcoming public advisory committee
meeting of the General and Plastic
Surgery Devices Panel of the Medical
Devices Advisory Committee. The
general function of the committee is to
provide advice and recommendations to
the Agency on FDA’s regulatory issues.
The meeting will be open to the public.
SUMMARY:
E:\FR\FM\26AUN1.SGM
26AUN1
]]>Agencies
[Federal Register Volume 86, Number 163 (Thursday, August 26, 2021)]
[Notices]
[Pages 47644-47645]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18453]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2021-0089]
Advisory Committee on Immunization Practices (ACIP); Amended
Notice of Meeting
AGENCY: Centers for Disease Control and Prevention, Department of
Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), announces the
following meeting of the Advisory Committee on Immunization Practices
(ACIP). This meeting is open to the public. Time will be available for
public comment. The meeting will be webcast live via the World Wide
Web; for more information on ACIP please visit the ACIP website: https://www.cdc.gov/vaccines/acip/.
DATES: The meeting will be held on August 30, 2021 and August 31, 2021,
from 10:00 a.m. to 4:00 p.m., EDT (times subject to change). The docket
is currently open to receive written comments. Written comments must be
received on or before August 31, 2021.
A notice of this ACIP meeting has also been posted on CDC's ACIP
website at: https://www.cdc.gov/vaccines/acip/. In addition,
CDC has sent notice of this ACIP meeting by email to those who
subscribe to receive email updates about ACIP.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0089 by any of the following methods:
[[Page 47645]]
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Centers for Disease Control and Prevention, 1600
Clifton Road NE, MS H24-8, Atlanta, Georgia 30329-4027, Attn: August
30-31, 2021 ACIP Meeting.
Instructions: All submissions received must include the Agency name
and Docket Number. All relevant comments received in conformance with
the https://www.regulations.gov suitability policy will be posted
without change to https://www.regulations.gov, including any personal
information provided. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee
Management Specialist, Centers for Disease Control and Prevention,
National Center for Immunization and Respiratory Diseases, 1600 Clifton
Road NE, MS-H24-8, Atlanta, GA 30329-4027; Telephone: 404-639-8367;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the
meeting of the Advisory Committee on Immunization Practices (ACIP);
August 24, 2021, 10:00 a.m.-5:00 p.m., EDT (times subject to change),
in the original FRN.
The virtual meeting was published in the Federal Register on
Wednesday, August 18, 2021, Volume 86, Number 157, pages 46256-46257.
The virtual meeting is being amended to change the dates to August
30, 2021 and August 31, 2021, update meeting times and supplemental
information.
In accordance with 41 CFR 102-3.150(b), less than 15 calendar days'
notice is being given for this meeting due to the exceptional
circumstances of the COVID-19 pandemic and rapidly evolving COVID-19
vaccine development and regulatory processes. A notice of this ACIP
meeting has also been posted on CDC's ACIP website at: https://www.cdc.gov/vaccines/acip/. In addition, CDC has sent notice
of this ACIP meeting by email to those who subscribe to receive email
updates about ACIP.
Purpose: The committee is charged with advising the Director, CDC,
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s,
the committee is mandated to establish and periodically review and, as
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines for Children (VFC) program,
along with schedules regarding dosing interval, dosage, and
contraindications to administration of vaccines. Further, under
provisions of the Affordable Care Act, section 2713 of the Public
Health Service Act, immunization recommendations of the ACIP that have
been approved by the Director of the Centers for Disease Control and
Prevention and appear on CDC immunization schedules must be covered by
applicable health plans.
Matters To Be Considered: The agenda will include discussions on
Pfizer's COVID-19 vaccine, and additional discussions on mRNA booster
doses. A recommendation vote on Pfizer's COVID-19 vaccine is planned.
No Vaccines for Children (VFC) votes are scheduled. Agenda items are
subject to change as priorities dictate. For more information on the
meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
Meeting Information: The meeting will be webcast live via the World
Wide Web; for more information on ACIP please visit the ACIP website:
https://www.cdc.gov/vaccines/acip/.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be posted on https://www.regulations.gov.
Therefore, do not include any information in your comment or supporting
materials that you consider confidential or inappropriate for public
disclosure. If you include your name, contact information, or other
information that identifies you in the body of your comments, that
information will be on public display. CDC will review all submissions
and may choose to redact, or withhold, submissions containing private
or proprietary information such as Social Security numbers, medical
information, inappropriate language, or duplicate/near duplicate
examples of a mass-mail campaign. CDC will carefully consider all
comments submitted into the docket.
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Oral public comment will occur
before any scheduled votes including all votes relevant to the ACIP's
Affordable Care Act and Vaccines for Children Program roles. Priority
will be given to individuals who submit a request to make an oral
public comment before the meeting according to the procedures below.
Procedure for Oral Public Comment: All persons interested in making
an oral public comment at the August 30, 2021, ACIP meeting must submit
a request at https://www.cdc.gov/vaccines/acip/meetings/ no later than
11:59 p.m., EDT, August 28, 2021, according to the instructions
provided.
If the number of persons requesting to speak is greater than can be
reasonably accommodated during the scheduled time, CDC will conduct a
lottery to determine the speakers for the scheduled public comment
session. CDC staff will notify individuals regarding their request to
speak by email by August 29, 2021. To accommodate the significant
interest in participation in the oral public comment session of ACIP
meetings, each speaker will be limited to 3 minutes, and each speaker
may only speak once per meeting.
Written Public Comment: The docket is currently open to receive
written comments. Written comments must be received on or before August
31, 2021.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-18453 Filed 8-24-21; 11:15 am]
BILLING CODE 4163-18-P
